Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Precancerous Conditions 51Leukemia 13Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Multiple Myeloma 10Neoplasms, Plasma Cell 9Myelodysplastic Syndromes 9Lymphoma, Non-Hodgkin 9Lymphoma, Mantle-Cell 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Acute 9Burkitt Lymphoma 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Myeloproliferative Disorders 8Monoclonal Gammopathy of Undetermined Significance 8Lymphoma, Large-Cell, Anaplastic 8Immunoblastic Lymphadenopathy 8Hodgkin Disease 8Waldenstrom Macroglobulinemia 7Lymphoma, T-Cell, Cutaneous 7Leukemia, Biphenotypic, Acute 7Uterine Cervical Dysplasia 6Primary Myelofibrosis 6Leukemia, Prolymphocytic 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6

Interventions

Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Tobacco Smoking × Other neoplasm × Clear all
NCT03347838 2025-12-12

Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers

University of Colorado, Denver

Phase 2 Active not recruiting
19 enrolled 10 charts
Head & NeckOther neoplasm

Tobacco Smoking, Head and Neck Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡